Autophagic activity was activated in the substantia nigra of rat models of Parkinson׳s disease.
Autophagy participates in the onset and development of Parkinson׳s disease.
Eldepryl exerts therapeutic effect on Parkinson׳s disease possibly by inhibiting the nerve cell autophagy.
This provides a novel pathway and target for drug treatment for Parkinson׳s disease.